N-Methylparoxetine CAS 110429-36-2: A Key Building Block for Pharmaceutical Innovation
In the intricate landscape of pharmaceutical development, specialized chemical compounds serve as the foundational building blocks for life-changing medications. N-Methylparoxetine, identified by its CAS number 110429-36-2, stands out as a critical intermediate, particularly in the synthesis of Paroxetine, a widely prescribed selective serotonin reuptake inhibitor (SSRI). For pharmaceutical companies and contract manufacturing organizations (CMOs), securing a dependable supply of high-quality N-Methylparoxetine is essential for driving innovation and ensuring the consistent production of vital medicines.
The primary application of N-Methylparoxetine lies in its role as a precursor in the multi-step synthesis of Paroxetine. The chemical structure of N-Methylparoxetine contains key functional groups that allow for further chemical modifications, ultimately leading to the active pharmaceutical ingredient (API). This makes it an indispensable component for any manufacturer involved in producing Paroxetine or related analogs. Procurement managers seeking to buy N-Methylparoxetine are thus looking for a material that not only meets stringent purity requirements but also integrates seamlessly into their established synthesis pathways.
The quality and purity of N-Methylparoxetine are paramount. Suppliers must guarantee a high assay, typically u226599%, along with adherence to global pharmacopoeial standards such as USP, BP, and EP. This ensures that the intermediate will perform predictably in subsequent reactions and that the final API will meet regulatory requirements for safety and efficacy. When researching how to purchase N-Methylparoxetine, it is crucial to partner with manufacturers who provide comprehensive documentation, including Certificates of Analysis (CoA), detailing lot-specific purity and impurity profiles.
The global market for N-Methylparoxetine is served by a network of manufacturers, with a significant presence in regions like China. These suppliers often offer competitive pricing, making it economically viable for pharmaceutical companies to procure this intermediate in the quantities needed for commercial production. For those looking to inquire about the price of N-Methylparoxetine, engaging with well-established suppliers who can offer both competitive rates and a secure supply chain is a wise strategy. Understanding lead times and minimum order quantities is also vital for effective planning.
In essence, N-Methylparoxetine (CAS 110429-36-2) is more than just a chemical compound; it is a vital link in the chain of pharmaceutical innovation. By prioritizing quality, working with reliable N-Methylparoxetine manufacturers, and understanding the market dynamics for procurement, pharmaceutical companies can ensure the consistent and cost-effective production of essential medications, thereby contributing to global health outcomes.
Perspectives & Insights
Bio Analyst 88
“This makes it an indispensable component for any manufacturer involved in producing Paroxetine or related analogs.”
Nano Seeker Pro
“Procurement managers seeking to buy N-Methylparoxetine are thus looking for a material that not only meets stringent purity requirements but also integrates seamlessly into their established synthesis pathways.”
Data Reader 7
“Suppliers must guarantee a high assay, typically u226599%, along with adherence to global pharmacopoeial standards such as USP, BP, and EP.”